Penn MS - Search Results

1

Targeted gene therapy for the treatment of cardiac dysfunction.

Askari AT, Penn MS. Askari AT, et al. Among authors: penn ms. Semin Thorac Cardiovasc Surg. 2002 Apr;14(2):167-77. doi: 10.1053/stcs.2002.32320. Semin Thorac Cardiovasc Surg. 2002. PMID: 11988956 Review.

2

Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction.

Askari AT, Brennan ML, Zhou X, Drinko J, Morehead A, Thomas JD, Topol EJ, Hazen SL, Penn MS. Askari AT, et al. Among authors: penn ms. J Exp Med. 2003 Mar 3;197(5):615-24. doi: 10.1084/jem.20021426. J Exp Med. 2003. PMID: 12615902 Free PMC article.

3

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS. Askari AT, et al. Among authors: penn ms. Lancet. 2003 Aug 30;362(9385):697-703. doi: 10.1016/S0140-6736(03)14232-8. Lancet. 2003. PMID: 12957092

4

Cellular, but not direct, adenoviral delivery of vascular endothelial growth factor results in improved left ventricular function and neovascularization in dilated ischemic cardiomyopathy.

Askari A, Unzek S, Goldman CK, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS. Askari A, et al. Among authors: penn ms. J Am Coll Cardiol. 2004 May 19;43(10):1908-14. doi: 10.1016/j.jacc.2003.12.045. J Am Coll Cardiol. 2004. PMID: 15145120 Free article.

5

An elderly man with syncope caused by right ventricular infarction and anomalous coronary vasculature.

Kim Y, Wang TH, Askari A, Penn MS. Kim Y, et al. Among authors: penn ms. Cleve Clin J Med. 2006 Jun;73(6):527-9, 533-4, 536. doi: 10.3949/ccjm.73.6.527. Cleve Clin J Med. 2006. PMID: 16784152 Free article. No abstract available.

6

Mechanical and electrical effects of cell-based gene therapy for ischemic cardiomyopathy are independent.

Deglurkar I, Mal N, Mills WR, Popovic ZB, McCarthy P, Blackstone EH, Laurita KR, Penn MS. Deglurkar I, et al. Among authors: penn ms. Hum Gene Ther. 2006 Nov;17(11):1144-51. doi: 10.1089/hum.2006.17.1144. Hum Gene Ther. 2006. PMID: 17069537

7

Cell-based gene therapy for the prevention and treatment of cardiac dysfunction.

Penn MS. Penn MS. Nat Clin Pract Cardiovasc Med. 2007 Feb;4 Suppl 1:S83-8. doi: 10.1038/ncpcardio0733. Nat Clin Pract Cardiovasc Med. 2007. PMID: 17230220

8

SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction.

Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, Koc ON, Penn MS. Zhang M, et al. Among authors: penn ms. FASEB J. 2007 Oct;21(12):3197-207. doi: 10.1096/fj.06-6558com. Epub 2007 May 11. FASEB J. 2007. PMID: 17496162

9

Exploitation of stem cell homing for gene delivery.

Penn MS, Khalil MK. Penn MS, et al. Expert Opin Biol Ther. 2008 Jan;8(1):17-30. doi: 10.1517/14712598.8.1.17. Expert Opin Biol Ther. 2008. PMID: 18081534 Review.

10

Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration.

Askari AT, Penn MS. Askari AT, et al. Among authors: penn ms. Discov Med. 2003 Oct;3(18):46-7. Discov Med. 2003. PMID: 20704864 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters